Lixte Biotechnology (LIXT) announced it has made an initial purchase of cryptocurrencies to further diversify its treasury holdings and for potential acquisitions. The company purchased 10.5 Bitcoin (BTC-USD) and 300 Ethereum (ETH-USD) for a total of approximately $2.6M as part of its strategy to strengthen its treasury position and expand its ability to transact across multiple mediums of exchange. Cryptocurrency now totals approximately 43.6% of Lixte’s treasury holdings. Recently, the company’s board of directors approved an increased allocation of up to 50%vof its treasury to cryptocurrencies.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LIXT:
- Lixte Biotechnology Appoints New CFO and Board Members
- Lixte Biotechnology appoints two new board members, Stazzone as CFO
- Lixte Biotechnology Raises $6.5M, Appoints New Management
- Lixte Biotechnology provides update on recent corporate activities
- Lixte Biotechnology Adopts Cryptocurrency in Treasury Policy